3327 related articles for article (PubMed ID: 9278044)
1. Alpha-synuclein in Lewy bodies.
Spillantini MG; Schmidt ML; Lee VM; Trojanowski JQ; Jakes R; Goedert M
Nature; 1997 Aug; 388(6645):839-40. PubMed ID: 9278044
[No Abstract] [Full Text] [Related]
2. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
3. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
5. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
6. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease.
Wakabayashi K; Mori F; Oyama Y; Kurihara A; Kamada M; Yoshimoto M; Takahashi H
Acta Neuropathol; 2003 Feb; 105(2):189-92. PubMed ID: 12536231
[TBL] [Abstract][Full Text] [Related]
7. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
9. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
10. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
12. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
14. [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C; Hauw JJ
Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
[TBL] [Abstract][Full Text] [Related]
15. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
16. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
17. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Hasegawa M; Goedert M
Proc Natl Acad Sci U S A; 1998 May; 95(11):6469-73. PubMed ID: 9600990
[TBL] [Abstract][Full Text] [Related]
19. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
20. alpha-synuclein and cytosolic dopamine: stabilizing a bad situation.
Sulzer D
Nat Med; 2001 Dec; 7(12):1280-2. PubMed ID: 11726961
[No Abstract] [Full Text] [Related]
[Next] [New Search]